Miller Aine 4
4 · Theravance Biopharma, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
Transactions
- Tax Payment
Ordinary Shares
[F1]2026-02-20$19.66/sh−16,851$331,291→ 184,161 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Signature
/s/ Brett A Grimaud, Attorney-in-Fact|2026-02-24